Undisclosed Ranipill-based therapeutic
/ PegBio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 09, 2026
Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
(GlobeNewswire)
- "Under the terms of the agreement, Rani and PegBio will collaborate on the preclinical development of RaniPill formulations for multiple molecules selected from PegBio's obesity and metabolic disease portfolio, with the goal of advancing the most promising candidates into clinical development."
Licensing / partnership • Obesity
1 to 1
Of
1
Go to page
1